BDBM534625 N-(6-(2,6-dimethylpyrimidin-4-yl)-4,6-dimethyl-5-oxo-5,6,7,8-tetrahydroquinolin-::US11229636, Compound 107::US11229636, Compound 108::US11229636, Compound 28

SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cc(C)c3C(=O)C(C)(CCc3n2)c2cc(C)nc(C)n2)cc1

InChI Key InChIKey=XYPLYKMWLBBBAE-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 534625   

TargetNuclear receptor ROR-gamma(Human)
Aurigene Discovery Technologies

US Patent
LigandPNGBDBM534625(US11229636, Compound 107 | N-(6-(2,6-dimethylpyrim...)
Affinity DataIC50: 150nMAssay Description:ROR gamma radioligand binding was performed using 3H 25-Hydroxycholesterol in a competitive displacement assay using dextran charcoal method. Using 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2022
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Aurigene Discovery Technologies

US Patent
LigandPNGBDBM534625(US11229636, Compound 107 | N-(6-(2,6-dimethylpyrim...)
Affinity DataIC50: 225nMAssay Description:ROR gamma radioligand binding was performed using 3H 25-Hydroxycholesterol in a competitive displacement assay using dextran charcoal method. Using 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2022
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Aurigene Discovery Technologies

US Patent
LigandPNGBDBM534625(US11229636, Compound 107 | N-(6-(2,6-dimethylpyrim...)
Affinity DataIC50: 300nMAssay Description:ROR gamma radioligand binding was performed using 3H 25-Hydroxycholesterol in a competitive displacement assay using dextran charcoal method. Using 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2022
Entry Details
US Patent